Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://luluiqho403982.myparisblog.com/39574267/retaglutide-a-promising-glp-1-receptor-agonist